The global healthcare industry is witnessing rapid transformation as immunotherapy continues to redefine cancer treatment approaches. Anti-PD-1 antibodies have emerged as one of the most promising therapeutic innovations in oncology, helping improve patient outcomes across multiple cancer indications. Increasing adoption of precision medicine, rising cancer prevalence, and continuous...

North America continues to lead the global immuno-oncology landscape, supported by advanced healthcare infrastructure, strong research capabilities, and significant investments in cancer therapeutics. The region has become a focal point for innovative antibody-based treatments that are transforming oncology care. Growing collaboration between biotechnology firms, pharmaceutical companies, and...